Johnson Donald E, Takahashi Masateru, Hamdan Samir M, Lee Seung-Joo, Richardson Charles C
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5312-7. doi: 10.1073/pnas.0701062104. Epub 2007 Mar 16.
T7 gene 5 DNA polymerase (gp5) and its processivity factor, Escherichia coli thioredoxin, together with the T7 gene 4 DNA helicase, catalyze strand displacement synthesis on duplex DNA processively (>17,000 nucleotides per binding event). The processive DNA synthesis is resistant to the addition of a DNA trap. However, when the polymerase-thioredoxin complex actively synthesizing DNA is challenged with excess DNA polymerase-thioredoxin exchange occurs readily. The exchange can be monitored by the use of a genetically altered T7 DNA polymerase (gp5-Y526F) in which tyrosine-526 is replaced with phenylalanine. DNA synthesis catalyzed by gp5-Y526F is resistant to inhibition by chain-terminating dideoxynucleotides because gp5-Y526F is deficient in the incorporation of these analogs relative to the wild-type enzyme. The exchange also occurs during coordinated DNA synthesis in which leading- and lagging-strand synthesis occur at the same rate. On ssDNA templates with the T7 DNA polymerase alone, such exchange is not evident, suggesting that free polymerase is first recruited to the replisome by means of T7 gene 4 helicase. The ability to exchange DNA polymerases within the replisome without affecting processivity provides advantages for fidelity as well as the cycling of the polymerase from a completed Okazaki fragment to a new primer on the lagging strand.
T7基因5 DNA聚合酶(gp5)及其持续性因子——大肠杆菌硫氧还蛋白,与T7基因4 DNA解旋酶一起,能在双链DNA上持续催化链置换合成(每次结合事件大于17,000个核苷酸)。这种持续性DNA合成对添加DNA陷阱具有抗性。然而,当正在积极合成DNA的聚合酶 - 硫氧还蛋白复合物受到过量DNA聚合酶的挑战时,交换很容易发生。这种交换可以通过使用一种基因改造的T7 DNA聚合酶(gp5 - Y526F)来监测,其中酪氨酸 - 526被苯丙氨酸取代。由gp5 - Y526F催化的DNA合成对链终止双脱氧核苷酸的抑制具有抗性,因为相对于野生型酶,gp5 - Y526F在掺入这些类似物方面存在缺陷。在领先链和滞后链合成以相同速率进行的协同DNA合成过程中也会发生交换。在仅含有T7 DNA聚合酶的单链DNA模板上,这种交换不明显,这表明游离的聚合酶首先通过T7基因4解旋酶被招募到复制体中。在复制体内交换DNA聚合酶而不影响持续性的能力,为保真度以及聚合酶从已完成的冈崎片段循环到滞后链上的新引物提供了优势。